Клінічне значення гопантенової терапії емоційних розладів у дітей, які потерпіли від психоемоційного насильства

Abstract

Рассмотрены эмоциональные расстройства (заниженная самооценка, высокий уровень тревожности, депрессивность, импульсивность, неуверенность в себе, скрытность, демонстративность и агрессивность) у детей вследствие психологического стрессирования. Изучена целесообразность применения гопантеновой кислоты в комплексной терапии с использованием методов психологической коррекции. Результаты проведенного исследования свидетельствуют о высокой эффективности сочетанного применения препарата «Пантогам» с методами психологической коррекции в терапии психоэмоциональных расстройств у детей, пострадавших от психологического насилия.

Cruelty and domestic violence are a serious problem of civilization in XXI century. The problem of psychotraumatic influence of violence on children is complex and includes not only psychological but also social and medico-legal aspects. In Ukraine violence in one or another form occurs in every second family. Each year about 2 million children under the age of 14 years are beaten by their parents, 10% of these children die, two thousand — make suicide. More than 50 thousand children a year escape from their own parents, and 25 thousand are wanted. The purpose of the study. To study efficiency of hopantenic acid as neuroprotective drugs in the treatment of emotional disorders in children suffering from psychological stress. Materials and methods. The study included 42 children aged 6–12 years who has suffered from various forms of violence. The children were divided into 2 groups of comparable gender and age. The study group comprised 14 boys and 7 girls who received hopantenic acid in combination with psychological treatment by methods of art therapy. The control group included 12 boys and 9 girls, they were treated that used only by the methods of psychological correction. Children from the main group in addition to psychological correction received nootropic drug at a dose of 0.25 g 3 times a day orally 15–30 minutes after meals for 28 days.